Bryan B. Molloy

2.8k total citations · 1 hit paper
62 papers, 2.3k citations indexed

About

Bryan B. Molloy is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Bryan B. Molloy has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 16 papers in Organic Chemistry. Recurrent topics in Bryan B. Molloy's work include Neurotransmitter Receptor Influence on Behavior (23 papers), Neuroscience and Neuropharmacology Research (16 papers) and Receptor Mechanisms and Signaling (7 papers). Bryan B. Molloy is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (23 papers), Neuroscience and Neuropharmacology Research (16 papers) and Receptor Mechanisms and Signaling (7 papers). Bryan B. Molloy collaborates with scholars based in United States, United Kingdom and Germany. Bryan B. Molloy's co-authors include Ray W. Fuller, Frank P. Bymaster, Jong S. Horng, Kenneth W. Perry, Dawn M. Wong, David T. Wong, Harold D. Snoddy, Kenneth L. Hauser, Norman R. Mason and Norbert Neuss and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Bryan B. Molloy

61 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine

1974 374 citations Frank P. Bymaster, Bryan B. Molloy et al. Life Sciences profile →

Peers

Countries citing papers authored by Bryan B. Molloy

Since Specialization

Citations

This map shows the geographic impact of Bryan B. Molloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan B. Molloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan B. Molloy more than expected).

Fields of papers citing papers by Bryan B. Molloy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan B. Molloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan B. Molloy. The network helps show where Bryan B. Molloy may publish in the future.

Co-authorship network of co-authors of Bryan B. Molloy

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan B. Molloy. A scholar is included among the top collaborators of Bryan B. Molloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan B. Molloy. Bryan B. Molloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·R W Fuller, Harold D. Snoddy, Bryan B. Molloy	20
2	Effect of norfenfluramine and two structural analogues on brain 5-hydroxyindoles and serum prolactin in rats 1982 ·Journal of Pharmacy and Pharmacology ·Ray W. Fuller, Harold D. Snoddy, James A. Clemens, Bryan B. Molloy	13
3	Structural relationships in the inhibition of [3H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazines 1980 ·Biochemical Pharmacology ·Ray W. Fuller, Norman R. Mason, Bryan B. Molloy	53
4	p-Iodoamphetamine as a serotonin depletor in rats. 1980 ·Journal of Pharmacology and Experimental Therapeutics ·R W Fuller, Harold D. Snoddy, (unknown), (unknown), (unknown), Bryan B. Molloy	15
5	Clofilium1--a new antifibrillatory agent that selectively increases cellular refractoriness 1979 ·Life Sciences ·Mitchell I. Steinberg, Bryan B. Molloy	43
6	A32390A, a new biologically active metabolite. II. Isolation and structure. 1978 ·The Journal of Antibiotics ·(unknown), Bryan B. Molloy, R. NAGARAJAN, James W. Martin, Jack B. Deeter, John L. Occolowitz	16
7	Inhibition in vitro of norepinephrine N-methyltransferase by 2-aminotetralins, analogs of phenylethylamines with rigid conformation 1977 ·Biochemical Pharmacology ·Ray W. Fuller, Bryan B. Molloy	6
8	Blockade of monoamine uptake by 1-amino-4-phenylbicyclo[2,2,2]octane (EXP 561) in rat brain and heart 1977 ·Neuropharmacology ·David T. Wong, Bryan B. Molloy, Frank P. Bymaster	10
9	Effects of kainic acid, a cyclic analogue of glutamic acid, on cyclic nucleotide accumulation in slices of rat cerebellum 1976 ·Brain Research ·Michael Schmidt, (unknown), Bryan B. Molloy	43
10	Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism 1975 ·Neuropharmacology ·Ray W. Fuller, John C. Baker, Kenneth W. Perry, Bryan B. Molloy	29
11	EFFECT OF 3-(p-TRIFLUOROMETHYLPHENOXY)-N-METHYL-3-PHENYLPROPYLAMINE ON THE DEPLETION OF BRAIN SEROTONIN BY 4-CHLOROAMPHETAMINE 1975 ·Journal of Pharmacology and Experimental Therapeutics ·Ray W. Fuller, Ken Perry, Bryan B. Molloy	25
12	Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. 1975 ·PubMed ·Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy	93
13	Effects of some homologues of 4-chloroamphetamine on brain serotonin metabolism 1974 ·Neuropharmacology ·Ray W. Fuller, Kenneth W. Perry, Dawn M. Wong, Bryan B. Molloy	7
14	EFFECT OF β,β-DIFLUORO SUBSTITUTION ON THE DISPOSITION AND PHARMACOLOGICAL EFFECTS OF 4-CHLOROAMPHETAMINE IN RATS 1973 ·Journal of Pharmacology and Experimental Therapeutics ·Ray W. Fuller, Harold D. Snoddy, Bryan B. Molloy	4
15	Further structure-activity studies on the lowering of brain 5-hydroxyindoles by 4-chloroamphetamine 1973 ·Neuropharmacology ·Ray W. Fuller, Harold D. Snoddy, (unknown), Bryan B. Molloy	17
16	Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 2. In vitro and in vivo studies with 2,3-dichloro-.alpha.-methylbenzylamine 1973 ·Journal of Medicinal Chemistry ·Ray W. Fuller, (unknown), Harold D. Snoddy, Bryan B. Molloy	30
17	CNS stimulant properties and physiologic disposition of ?,?-difluorophenylethylamine in mice 1973 ·Psychopharmacology ·Ray W. Fuller, Harold D. Snoddy, Bryan B. Molloy, (unknown)	1
18	3-METHYL-3-BUTEN-1-OL AND 3-BUTEN-1-OL 1972 ·Organic Preparations and Procedures International ·Robin B. Kinnel, Bryan B. Molloy, Donald W. Graham, Kenn E. Harding	2
19	A NEW DIPEPTIDE ANTIBIOTIC FROM STREPTOMYCES COLLINUS, LINDENBEIN 1972 ·The Journal of Antibiotics ·Bryan B. Molloy, (unknown), Richard M. Gale, Marvin Gorman, L. D. BOECK, (unknown), Renate Kastner, L. L. HUCKSTEP, Norbert Neuss	30
20	805. Nuclear magnetic resonance. Part III. The structure of pyrrolo[2,1-b]thiazolium cations 1965 ·Journal of the Chemical Society (Resumed) ·Bryan B. Molloy, (unknown), (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact